Next Article in Journal
The Comparative Safety and Efficacy of Resmetirom and Semaglutide in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Systematic Review
Previous Article in Journal
Agreement Between Medico-Administrative Database Algorithms and Survey-Based Diagnoses for Depression and Anxiety in Older Adults
Previous Article in Special Issue
Off-Label Use of Dalbavancin in Enterococcus spp. Abscess and Streptococcus pneumoniae Bacteremia Secondary to Septic Arthritis: A Retrospective Case Report
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Special Issue on Anti-Infectives: Pharmacoepidemiology and Clinical Pharmacology

School of Pharmacy and Pharmaceutical Sciences, University of California, Irvine, CA 92697, USA
Pharmacoepidemiology 2025, 4(3), 13; https://doi.org/10.3390/pharma4030013
Submission received: 4 June 2025 / Accepted: 11 June 2025 / Published: 23 June 2025
(This article belongs to the Special Issue Anti-Infectives: Pharmacoepidemiology and Clinical Pharmacology)

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

The exchange of knowledge is fundamental to the progression of health sciences [...]

Share and Cite

MDPI and ACS Style

Nguyen, L. Special Issue on Anti-Infectives: Pharmacoepidemiology and Clinical Pharmacology. Pharmacoepidemiology 2025, 4, 13. https://doi.org/10.3390/pharma4030013

AMA Style

Nguyen L. Special Issue on Anti-Infectives: Pharmacoepidemiology and Clinical Pharmacology. Pharmacoepidemiology. 2025; 4(3):13. https://doi.org/10.3390/pharma4030013

Chicago/Turabian Style

Nguyen, Lee. 2025. "Special Issue on Anti-Infectives: Pharmacoepidemiology and Clinical Pharmacology" Pharmacoepidemiology 4, no. 3: 13. https://doi.org/10.3390/pharma4030013

APA Style

Nguyen, L. (2025). Special Issue on Anti-Infectives: Pharmacoepidemiology and Clinical Pharmacology. Pharmacoepidemiology, 4(3), 13. https://doi.org/10.3390/pharma4030013

Article Metrics

Back to TopTop